MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
19.90
-0.09 (-0.45%)
At close: Jun 26, 2026, 4:00 PM EDT
20.25
+0.35 (1.76%)
After-hours: Jun 26, 2026, 7:46 PM EDT
MLTX Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for MLTX stock have an average target of 30.69, with a low estimate of 6.00 and a high estimate of 70. The average target predicts an increase of 54.22% from the current stock price of 19.90.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MLTX stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 11 | 11 | 10 | 10 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 3 | 3 | 2 | 2 | 2 | 2 |
| Total | 17 | 16 | 16 | 16 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $45 | Buy | Reiterates | $45 | +126.13% | Jun 24, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Reiterates $40 | Buy | Reiterates | $40 | +101.01% | Jun 23, 2026 |
| BTIG | BTIG | Buy Maintains $30 | Buy | Maintains | $30 | +50.75% | Jun 23, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $33 | Buy | Maintains | $33 | +65.83% | Jun 22, 2026 |
| Clear Street | Clear Street | Buy Maintains $70 | Buy | Maintains | $70 | +251.76% | Jun 22, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
19.44M
EPS This Year
-3.86
from -3.53
EPS Next Year
-3.45
from -3.86
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 41.5M | |
| Avg | n/a | 19.4M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 1,187.8% |
| Avg | - | 644.1% |
| Low | - | -29.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.25 | -2.90 | |
| Avg | -3.86 | -3.45 | |
| Low | -5.16 | -4.56 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.